At GBSG, our mission is to revolutionize diabetes management.
More than 114 million people in China are living with diabetes – that’s one quarter of people with diabetes globally. Through innovative technology, our goal is to free people living with diabetes in China from painful and invasive blood monitoring devices, giving them a better quality of life.
Glucose Biosensor Systems (Greater China) Holdings, Inc. (GBSG) is a biosensor diagnostic technology company focused on commercializing the Saliva Glucose Biosensor in Mainland China, Hong Kong, Vietnam and Bangladesh.
GBSG is a proud member of The iQ Group Global, a group of companies committed to creating the medicines of the future. What starts here changes the world.
The world’s first non-invasive, saliva-based glucose test for diabetes management SYDNEY – February , 2019 – The iQ Group Global, a consortium of life science and financial services companies which […]
The Saliva Glucose Biosensor
Eliminating the need for finger-prick blood testing
The Saliva Glucose Biosensor is the first non-invasive, saliva-based glucose test for diabetes management that measures glucose in saliva, not blood.
Through the regulatory process we intend to demonstrate that the saliva glucose test can be used as a point of care self-test, indicated for the management of diabetes, as non-adjunctive to blood glucose testing for diabetes treatment decisions.
For illustrative purposes only and has yet to receive regulatory approval in any jurisdiction.